The healthcare CMO market was valued at US$ 80,479.4 million in 2018 and it is projected to reach US$ 223,355.6 million in 2027; it is expected to grow at a CAGR of 12.2% from 2019 to 2027.
Contract manufacturing organization (CMO) also known as contract development and manufacturing organization is a company that serves several other companies in the medical devices as well as pharmaceutical and biopharmaceutical sector with comprehensive services from development, manufacturing to packaging. These services are outsourced by various OEM players in the business in order to help with the scalability, and save marginally on production costs. The growth of the global healthcare CMO market is attributed to the increasing inclination of pharmaceutical and medical device manufacturers towards outsourcing, increasing patent cliffs, rising geriatric population coupled with the increasing production of drugs & medical device. However, lack of skilled professionals is the major factor hindering the market growth.
The global healthcare CMO market is expected to witness substantial growth. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.
Lucrative Regions for Global Healthcare CMO Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Increasing Patent Cliffs to Drive Global Healthcare CMO Market Growth
The growth of the healthcare CMO market is majorly driven by the pharmaceutical industry, the increase in the production of the generic medicinal products across the world. The production of the generic drugs is increased due to the expiry of the patented drugs. The expiry of the patents create a huge scope for the generic manufacturer to produce generic drugs for various therapeutic areas. The production of the generic drugs are manufactured with the low cost compared to the innovative drugs. Each year the pharmaceutical industry gets distressed by patent expirations that threaten the sales of innovative medications.
The healthcare CMO market is likely to grow in the developing regions such as Europe and Asia Pacific, among which Asia Pacific is estimated to be the fastest growing market. The regions is consolidated with the various generic drug manufacturers. The demands for the therapeutics drugs are higher from countries such Italy, Germany, China and India among the other countries. The competition for the manufacturing of the generic drugs is much higher and the closer government support for the manufacturing are likely to fuel the growth of the market.
The rising numbers of the contract manufacturing across the globe are entering in the production of the generic drugs as the legislation encouraged competition to benefit consumers. The CMOs help in the manufacturing the drug with the bioequivalence testing and the drugs are produced with the current good manufacturing practices. The CMO allows to reduce the cost of manufacturing and enhance the production in bulk quantities. Additionally as per the EvaluatePharma statistics it is stated that approximately US$ 194 billion in the innovative drugs sales are at risk during the 2017- 2020. Also an estimate of nearly US$ 31 billion could be lost due to the expiry of patents alone in 2018. Therefore, owing to the above mentioned factors the market for the healthcare CMO is likely to propel during the forecast period.
Service-Based Insights
In terms of service, the global healthcare CMO market is segmented into pharmaceutical contract manufacturing services and medical device contract manufacturing services. In 2018, pharmaceutical contract manufacturing services segment held largest share of the market. Also, the same segment is estimated to register the highest CAGR during the forecast period.
Global Healthcare CMO Market, by Service – 2018 and 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Healthcare CMO Market: Strategic Insights
Market Size Value in US$ 80,479.4 Million in 2018 Market Size Value by US$ 223,355.6 Million by 2027 Growth rate CAGR of 12.2% from 2019-2027 Forecast Period 2019-2027 Base Year 2018
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Healthcare CMO Market: Strategic Insights
| Market Size Value in | US$ 80,479.4 Million in 2018 |
| Market Size Value by | US$ 223,355.6 Million by 2027 |
| Growth rate | CAGR of 12.2% from 2019-2027 |
| Forecast Period | 2019-2027 |
| Base Year | 2018 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
The global healthcare CMO market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.
Global Healthcare CMO Market – by Service
- Pharmaceutical Contract Manufacturing Services
- Active Pharmaceutical Ingredients (API) Manufacturing
- Final Dosage Form Manufacturing
- Packaging
- Medical Device Contract Manufacturing Services
- Outsourcing Design
- Device Manufacturing
- Final Goods Assembly
Global Healthcare CMO Market – by Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
South America and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Company Profiles
- Royal DSM
- Catalent, Inc
- Boehringer Ingelheim International GmbH
- Recipharm AB (publ)
- Fareva
- Lonza
- Piramal Enterprises Ltd
- Dr. Reddy’s Laboratories Ltd.
- Almac Group
- FAMAR Health Care Services.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Service , and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
1. INTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 market segmentation
1.3.1 Global Healthcare CMO Market – By Service
1.3.2 Global Healthcare CMO Market – By Geography
2. Global healthcare cmo market – Key takeaways
3. research Methodology
3.1.1 Coverage
3.1.2 Secondary Research
3.1.3 Primary Research
4. Global Healthcare CMo– market landscape
4.1 overview
4.2 pest analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe– PEST Analysis
4.2.3 Asia Pacific– PEST Analysis
4.2.4 Middle East & South Africa– PEST Analysis
4.2.5 South and Central America – PEST Analysis
5. Global healthcare cmo market – Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Inclination of Pharmaceutical and Medical Device Manufacturers Towards Outsourcing
5.1.2 Increasing Patent Cliffs
5.1.3 Rising Geriatric Population Coupled With The Increasing Production of Drug s& Medical Devices
5.2 Key Market Challenges
5.2.1 Lack of Skilled Professionals for CMO
5.3 Key Market Opportunities
5.3.1 Rising Demand in Developing Regions
5.3.2 Growth Opportunities Due to Biosimilars Market
5.4 Market trend
5.4.1 Rise in Market Consolidation
5.5 Impact analysis
6. Healthcare CMO market – Global Analysis
6.1 global healthcare CMo market Revenue Forecasts and Analysis
6.2 global healthcare cmo market, By Geography - Forecasts and Analysis
6.3 PERFORMANCE OF KEY PLAYERS
6.3.1 Catalent, Inc.
6.3.2 Lonza
6.3.3 Integer Holdings Corporation
6.3.4 Flex Ltd
6.4 expert opinions
7. Global Healthcare CMO Market analysis– by Service
7.1 overview
7.2 Global healthcare CMO Market BY Service, 2018 & 2027 (%)
7.3 Pharmaceutical contract manufacturing services Market
7.3.1 Overview
7.3.2 Global Pharmaceutical Contract Manufacturing Services Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.3 Active Pharmaceutical Ingredients (API) Market
7.3.3.1 Overview
7.3.3.2 Global Active Pharmaceutical Ingredients (API) Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.4 Final Dosage Form Manufacturing Market
7.3.4.1 Overview
7.3.4.2 Global Final Dosage Form Manufacturing Market Revenue and Forecasts to 2027 (US$ Mn)
7.3.5 Packaging Market
7.3.5.1 Overview
7.3.5.2 Global Packaging Market Revenue and Forecasts to 2027 (US$ Mn)
7.4 medical Device COntract Manufacturing Services market
7.4.1 Overview
7.4.2 Global Medical Device Contract Manufacturing Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.3 Outsourcing Design Market
7.4.3.1 Overview
7.4.3.2 Global Outsourcing Design Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.4 Device Manufacturing Market
7.4.4.1 Overview
7.4.4.2 Global Device Manufacturing Market Revenue and Forecasts to 2027 (US$ Mn)
7.4.5 Final Goods Assembly Market
7.4.5.1 Overview
7.4.5.2 Global Final Goods Assembly Market Revenue and Forecasts to 2027 (US$ Mn)
8. Healthcare CMO MARKET REVENUE AND FORECASTS TO 2027 – GEOGRAPHICAL ANALYSIS
8.1 north america Healthcare CMO market
8.1.1 Overview
8.1.2 North America Healthcare CMO Market Revenue And Forecasts to 2027 (US$ Mn)
8.1.3 North America Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
8.1.3.1 North America Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.1.3.2 North America Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.1.4 North America Healthcare CMO Market Revenue And Forecasts to 2027, By Country (%)
8.1.5 US Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
8.1.5.1 US Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
8.1.5.2 US Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
8.1.5.2.1 US Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.1.5.2.2 US Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.1.6 Canada Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
8.1.6.1 Canada Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
8.1.6.2 Canada Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
8.1.6.2.1 Canada Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.1.6.2.2 Canada Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.1.7 Mexico Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
8.1.7.1 Mexico Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
8.1.7.2 Mexico Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
8.1.7.2.1 Mexico Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.1.7.2.2 Mexico Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.2 Europe healthcare cmo market
8.2.1 Overview
8.2.2 Europe Healthcare CMO Market Revenue And Forecasts to 2027 (US$ Mn)
8.2.3 Europe Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
8.2.3.1 Europe Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.2.3.2 Europe Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.2.4 Europe Healthcare CMO Market Revenue And Forecasts to 2027, By Country (%)
8.2.5 Germany Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
8.2.5.1 Germany Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
8.2.5.2 Germany Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
8.2.5.2.1 Germany Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.2.5.2.2 Germany Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.2.6 UK Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
8.2.6.1 UK Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
8.2.6.2 UK Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
8.2.6.2.1 UK Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.2.6.2.2 UK Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.2.7 France Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
8.2.7.1 France Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
8.2.7.2 France Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
8.2.7.2.1 France Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.2.7.2.2 France Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.2.8 Spain Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
8.2.8.1 Spain Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
8.2.8.2 Spain Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
8.2.8.2.1 Spain Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.2.8.2.2 Spain Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.2.9 Italy Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
8.2.9.1 Italy Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
8.2.9.2 Italy Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
8.2.9.2.1 Italy Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.2.9.2.2 Italy Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3 ASIA PAcific Healthcare CMO MARKET
8.3.1 Overview
8.3.2 Asia Pacific Healthcare CMO Market Revenue And Forecasts to 2027 (US$ Mn)
8.3.3 Asia Pacific Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
8.3.3.1 Asia Pacific Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.3.2 Asia Pacific Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.4 Asia Pacific Healthcare CMO Market Revenue And Forecasts to 2027, By Country (%)
8.3.5 China Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
8.3.5.1 China Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
8.3.5.2 China Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
8.3.5.2.1 China Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.5.2.2 China Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.6 Japan Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
8.3.6.1 Japan Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
8.3.6.2 Japan Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
8.3.6.2.1 Japan Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.6.2.2 Japan Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.7 India Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
8.3.7.1 India Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
8.3.7.2 India Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
8.3.7.2.1 India Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.7.2.2 India Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.8 Australia Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
8.3.8.1 Australia Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
8.3.8.2 Australia Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
8.3.8.2.1 Australia Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.8.2.2 Australia Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.9 South Korea Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
8.3.9.1 South Korea Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
8.3.9.2 South Korea Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
8.3.9.2.1 South Korea Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.3.9.2.2 South Korea Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.4 Middle East & Africa Healthcare CMO market
8.4.1 Middle East & Africa Healthcare CMO Market Revenue And Forecasts to 2027 (US$ Mn)
8.4.2 Middle East & Africa Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
8.4.2.1 Middle East & Africa Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.4.2.2 Middle East & Africa Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.4.3 Middle East & Africa Healthcare CMO Market Revenue And Forecasts to 2027, By Country (%)
8.4.4 UAE Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
8.4.4.1 UAE Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
8.4.4.2 UAE Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
8.4.4.2.1 UAE Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.4.4.2.2 UAE Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.4.5 Saudi Arabia Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
8.4.5.1 Saudi Arabia Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
8.4.5.2 Saudi Arabia Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
8.4.5.2.1 Saudi Arabia Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.4.5.2.2 Saudi Arabia Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.4.6 South Africa Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
8.4.6.1 South Africa Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
8.4.6.2 South Africa Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
8.4.6.2.1 South Africa Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.4.6.2.2 South Africa Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.5 SOUTH AND CENTRAL AMERICA HEALTHCARE CMO MARKET
8.5.1 Overview
8.5.2 South and Central America Healthcare CMO Market Revenue And Forecasts to 2027 (US$ Mn)
8.5.3 South and Central America Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
8.5.3.1 South and Central America Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.5.3.2 South and Central America Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.5.4 South and Central America Healthcare CMO Market Revenue And Forecasts to 2027, By Country (%)
8.5.5 Brazil Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
8.5.5.1 Brazil Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
8.5.5.2 Brazil Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
8.5.5.2.1 Brazil Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.5.5.2.2 Brazil Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.5.6 Argentina Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
8.5.6.1 Argentina Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
8.5.6.2 Argentina Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
8.5.6.2.1 Argentina Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
8.5.6.2.2 Argentina Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
9. Healthcare CMO MARKET – Industry Landscape
9.1 Overview
9.2 Growth Strategies in the healthcare CMO Market, 2015-2018
9.3 Organic Developments
9.3.1 Overview
9.4 Organic Growth Strategies in the healthcare CMO Market, 2016-2018
9.5 Expansion
9.5.1 Recent Expansion By Players in the Healthcare CMO Market, 2015-2018
9.6 Service Launch
9.6.1 Recent Service Launch By Players in the Healthcare CMO Market, 2015-2018
9.7 Others
9.7.1 Others Organic Strategies Made by the Players in the Healthcare CMO Market, 2015-2018
9.8 Inorganic developments
9.8.1 Overview
9.9 inOrganic Growth Strategies in the healthcare CMO Market, 2015-2018
9.10 Agreement
9.10.1Agreement Made by the Players in the Healthcare CMO Market, 2015-2018
9.11 Acquisition
9.11.1Acquisition Made by the Players in the Healthcare CMO Market, 2015-2018
9.12 Partnerships
9.12.1.... Recent Partnership by Players in the healthcare CMO Market, 2015-2018
9.13 Collaboration
9.13.1..... Collaboration By Players in the Healthcare CMO Market, 2015-2018
10. Healthcare CMO market–Key company profiles
10.1 Royal DSM
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Financial Overview
10.1.4 Service Portfolio
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Catalent, Inc
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Financial Overview
10.2.4 Service Portfolio
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Boehringer Ingelheim International GmbH
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Financial Overview
10.3.4 Service Portfolio
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Recipharm AB (publ)
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Financial Overview
10.4.4 Service Portfolio
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Fareva
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Financial Overview
10.5.4 Service Portfolio
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 LONZA
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Financial Overview
10.6.4 Service Portfolio
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Piramal Enterprises Ltd.
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Financial Overview
10.7.4 Service Portfolio
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Dr. Reddy’s Laboratories Ltd.
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Financial Overview
10.8.4 Service Portfolio
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Almac Group
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Financial Overview
10.9.4 Service Portfolio
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 FAMAR Health Care Services
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Financial Overview
10.10.4 Service Portfolio
10.10.5 SWOT Analysis
10.10.6 Key Developments
11. Appendix
11.1 About The Insight Partners
11.2 Glossary of Terms
LIST OF TABLES
TABLE 1. R&D Investments by major pharmaceutical & MEdical Device companies
TABLE 2. Consolidation in pharmaceutical & MEdical Device companies
TABLE 3. North America Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
TABLE 4. North America Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Service (US$ Mn)
TABLE 5. North America Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 6. US Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
TABLE 7. US Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 8. US Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 9. Canada Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
TABLE 10. Canada Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 11. Canada Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 12. Mexico Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
TABLE 13. Mexico Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 14. Mexico Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 15. Europe Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
TABLE 16. Europe Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Service (US$ Mn)
TABLE 17. Europe Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 18. Germany Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
TABLE 19. Germany Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 20. Germany Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 21. UK Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
TABLE 22. UK Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 23. UK Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 24. France Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
TABLE 25. France Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 26. France Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 27. Spain Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
TABLE 28. Spain Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 29. Spain Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 30. Italy Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
TABLE 31. Italy Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 32. Italy Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 33. Asia Pacific Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
TABLE 34. Asia Pacific Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Service (US$ Mn)
TABLE 35. Asia Pacific Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 36. China Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
TABLE 37. China Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 38. China Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 39. Japan Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
TABLE 40. Japan Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 41. Japan Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 42. India Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
TABLE 43. India Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 44. India Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 45. Australia Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
TABLE 46. Australia Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 47. Australia Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 48. South Korea Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
TABLE 49. South Korea Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 50. South Korea Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 51. Middle East & Africa Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
TABLE 52. Middle East & Africa Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Service (US$ Mn)
TABLE 53. Middle East & Africa Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 54. UAE Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
TABLE 55. UAE Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 56. UAE Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 57. Saudi Arabia Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
TABLE 58. Saudi Arabia Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 59. Saudi Arabia Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 60. South Africa Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
TABLE 61. South Africa Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 62. South Africa Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 63. South and Central America Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
TABLE 64. South and Central America Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Service (US$ Mn)
TABLE 65. South and Central America Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By Type (US$ Mn)
TABLE 66. Brazil Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
TABLE 67. Brazil Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 68. Brazil Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 69. Argentina Healthcare CMO Market Revenue And Forecasts to 2027, By Service (US$ Mn)
TABLE 70. Argentina Pharmaceutical Contract Manufacturing Services Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 71. Argentina Medical Device Contract Manufacturing Services Market Revenue And Forecasts to 2027, By type (US$ Mn)
TABLE 72. Recent Expansion By Players in the healthcare CMO Market, 2015-2018
TABLE 73. Recent Service Launch By Players in the healthcare CMO Market, 2015-2018
TABLE 74. Others Organic Strategies Made by the Players in the Healthcare CMO Market, 2015-2018
TABLE 75. Agreement made by the players in the healthcare cmo market, 2015-2018
TABLE 76. Acquisition made by the players in the healthcare cmo market, 2015-2018
TABLE 77. Recent Partnership in the healthcare CMO Market, 2015-2018
TABLE 78. Collaboration in the healthcare CMO Market, 2015-2018
TABLE 79. Glossary of Terms, Healthcare CMO market
LIST OF FIGURES
FIGURE 1. Healthcare CMo market Segmentation
FIGURE 2. Healthcare Cmo Segmentation, by region
FIGURE 3. Asia Pacific Healthcare CMo market, Revenue (US$ Mn), By Geography 2018 & 2027
FIGURE 4. Global healthcare cmo market By service, Market Share (%), 2018
FIGURE 5. North America PEST Analysis
FIGURE 6. Europe PEST Analysis
FIGURE 7. Asia pacific PEST Analysis
FIGURE 8. Middle East & South Africa PEST Analysis
FIGURE 9. South and central america PEST Analysis
FIGURE 10. Number of approvals for NDA & BLA (2005 to 2016)
FIGURE 11. Healthcare CMo market impact analysis of driver and Challenges
FIGURE 12. global healthcare cmo market – Revenue Forecasts and Analysis –2017- 2027
FIGURE 13. global healthcare cmo market – by geography Forecasts and Analysis – 2018- 2027
FIGURE 14. Global healthcare CMO Market, by service 2018 & 2027 (%)
FIGURE 15. Global Pharmaceutical Contract Manufacturing Services Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 16. Global Active Pharmaceutical Ingredients (API) Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 17. Global final dosage form manufacturing Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 18. Global packaging Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 19. Global Medical Device Contract Manufacturing Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 20. Global Outsourcing Design Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 21. Global Device Manufacturing Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 22. Global Final Goods Assembly Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 23. North America Healthcare CMO Market revenue Overview, by Country (2017) (us $ mn)
FIGURE 24. North America Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 25. North America Healthcare CMO Market Revenue And Forecasts to 2027, By Country (%)
FIGURE 26. US Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 27. Canada Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 28. Mexico Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 29. Europe Healthcare CMO Market revenue Overview, by Country (2017) (us $ mn)
FIGURE 30. Europe Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 31. Europe Healthcare CMO Market Revenue And Forecasts to 2027, By Country (%)
FIGURE 32. Germany Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 33. UK Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 34. France Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 35. Spain Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 36. Italy Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 37. ASIA PAcific Healthcare CMO Market revenue Overview, by Country (2017) (us $ mn)
FIGURE 38. Asia Pacific Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 39. Asia Pacific Healthcare CMO Market Revenue And Forecasts to 2027, By Country (%)
FIGURE 40. China Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 41. Japan Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 42. India Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 43. Australia Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 44. South Korea Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 45. Middle East & Africa Healthcare CMO Market revenue Overview, by Country (2017) (us $ mn)
FIGURE 46. Middle East & Africa Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 47. Middle East & Africa Healthcare CMO Market Revenue And Forecasts to 2027, By Country (%)
FIGURE 48. UAE Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 49. Saudi Arabia Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 50. South Africa Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 51. South and Central america Healthcare CMO Market revenue Overview, by Country (2017) (us $ mn)
FIGURE 52. South and Central America Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 53. South and Central America Healthcare CMO Market Revenue And Forecasts to 2027, By Country (%)
FIGURE 54. Brazil Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 55. Argentina Healthcare CMO Market Revenue and Forecasts to 2027 (US$ Mn)
FIGURE 56. Growth Strategies in the healthcare CMO Market, 2015-2018
FIGURE 57. Organic Growth Strategies in the healthcare CMO Market, 2016-2018
FIGURE 58. Inorganic developments in the healthcare CMO Market, 2015-2018
The List of Companies
- Royal DSM
- Catalent, Inc
- Boehringer Ingelheim International GmbH
- Recipharm AB (publ)
- Fareva
- Lonza
- Piramal Enterprises Ltd
- Dr. Reddy’s Laboratories Ltd.
- Almac Group
- FAMAR Health Care Services
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Healthcare CMO Market
Mar 2019
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2019
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2019
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2019
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Mar 2019
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Mar 2019
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Mar 2019
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Mar 2019